Evidence map›Paper›PMID 39234200›Full record

ArticleAging medicine (Milton (N.S.W))2024

Analysis of mortality in Parkinson disease in China: Exploration of recent and future trends.

Jinxin Lan, Yifan Ren, Ge Song, Lu Liu, Mingyu Li, Renmu Zhang, Chunyu Yin, Hua Zhou, Xiangyuan Zhang, Bin Lv and 1 more

Abstract read
In one paragraph

Article in Aging medicine (Milton (N.S.W)), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jinxin LanThe First Medical Center Chinese PLA General Hospital Beijing China.ORCID https://orcid.org/0009-0001-1688-8898
Yifan RenThe First Medical Center Chinese PLA General Hospital Beijing China.ORCID https://orcid.org/0000-0002-4100-8952
Ge SongDepartment of Health Care 305 Hospital of Chinese PLA Beijing China.
Lu LiuTaiyuan Wanbailin Medical Group Central Hospital Taiyuan China.
Mingyu LiDepartment of Internal Medicine Gucheng County Hospital of Traditional Chinese Medicine Hengshui Hebei China.
Renmu ZhangDepartment of Neurology Sinopharm Tongmei General Hospital Datong Shanxi China.
Chunyu YinThe First Medical Center Chinese PLA General Hospital Beijing China.
Hua ZhouDepartment of Neurology Tangshan Hospital of Traditional Chinese Medicine Tangshan Hebei China.
Xiangyuan ZhangThe First Medical Center Chinese PLA General Hospital Beijing China.
Bin LvThe First Medical Center Chinese PLA General Hospital Beijing China.ORCID https://orcid.org/0000-0001-9858-8778
Yaqi MaThe First Medical Center Chinese PLA General Hospital Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Parkinson disease (PD) is the third leading cause of mortality among middle-aged and older individuals in China. This study aimed to explore the trends and distribution features of PD mortality in China from 2013 to 2021 and make predictions for the next few decades. Methods: Relevant data were obtained from the Chinese Center for Disease Control and Prevention Disease Surveillance Point system. The joinpoint regression model was used to evaluate trends. The R software was used to predict future trends. Results: Age-standardized mortality rate (ASMR) of PD increased from 0.59 per 100,000 individuals to 1.22 per 100,000 individuals from 2013 to 2021, with an average annual percent change (AAPC) of 9.50 (95% CI: 8.24-10.78). The all-age ASMR of PD were higher in male individuals than in female individuals, and ASMR increased with age. The number of deaths and ASMR increased gradually from west to east and from rural to urban areas. Furthermore, ASMR is expected to increase to 2.66 per 100,000 individuals by 2040. Conclusions: The heightened focus on the ASMR of PD among male individuals, urban areas, eastern China, and individuals aged ≥85 years has become a key determinant in further decreasing mortality, thereby exhibiting novel challenges to effective strategies for disease prevention and control.

Indexed as

agingChinajoinpoint regression modelmortalityParkinson disease

Identifiers

PMID39234200
PMCPMC11369336

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.